Class Action for Those Injured by Gadolinium Contrast MRIs

Rhode Island's WPRI News reported that "in a massive lawsuit," 517 plaintiffs are suing "pharmaceutical companies that make certain dyes used for magnetic resonance imaging (MRI)." The plaintiffs were "diagnosed with nephrogenic systemic fibrosis (NSF)...after being injected with a contrast-agent made with gadolinium." Patients with healthy kidneys are able to "simply flush the gadolinium out," but those with NSF "describe their skin turning wood-like, eventually cracking." The FDA "issued a warning in 2006 and 2007 not to administer the drug to those with kidney problems," but "gadolinium is still used in routine MRIs." The class-action suit "against five pharmaceutical companies that make gadolinium-based contrasting agents is getting larger as more and more are diagnosed with NSF." Some claim that they were "never warned about the possible side-effect because the medical community was in the dark at the time."